Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
01/26/1989 | WO1989000426A1 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
01/26/1989 | WO1989000422A2 Thiosulphinic acid derivatives, their use in the treatment of inflammatory diseases, and drugs containing them |
01/25/1989 | EP0300842A1 Pharmaceutical or cosmetic composition containing hydroquinone and kojic acid in liposomes |
01/25/1989 | EP0300725A1 Tetrahydroisoquinolin-2-yl derivatives as thromboxane A2 antagonists |
01/25/1989 | EP0300676A2 Tetrahydrocarbazole 1-alkanoic acids |
01/25/1989 | EP0300675A2 Method for the improvement of cyclosporine therapy |
01/25/1989 | EP0300523A1 Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints |
01/25/1989 | EP0300404A2 Di-and tetrahydronapthyl anti-allergy agents |
01/25/1989 | EP0300397A2 Hydroxy-, Alkoxy- and Benzyloxy substituted phospholipids, a process for their preparation and their use as medicaments |
01/25/1989 | EP0300325A2 Compositions for promoting growth of animals |
01/25/1989 | EP0300189A2 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
01/25/1989 | CN1030586A Cycloalkylamides of (8beta)-1-alkyl-6-(substituted) ergolines |
01/24/1989 | US4800225 Pharmacologically active hydrated azabicyclo compound |
01/24/1989 | CA1249399A1 Process for preparing v.sub.1-vasopressin antagonists |
01/24/1989 | CA1249396A1 Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis |
01/24/1989 | CA1249394A1 Compounds for treating hypertension |
01/24/1989 | CA1249293A1 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease |
01/24/1989 | CA1249292A1 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease |
01/19/1989 | DE3822792A1 Use of 5-HT3 antagonists |
01/19/1989 | DE3722647A1 Galenische verwendung eines tripeptids als arzneimittel Pharmaceutical use of a tripeptide as drug |
01/18/1989 | EP0299937A1 A composition based on phosphatidylcholine and medical uses thereof |
01/18/1989 | EP0299914A1 9-Halogen (Z) prostaglandin derivatives, process for their production and their use as medicines |
01/18/1989 | EP0299761A1 Anti-inflammatory aryl derivatives |
01/18/1989 | EP0299683A2 Heterocyclic olefinic compounds and their use as aromatase inhibitors |
01/18/1989 | EP0299663A2 Antihistaminic aromatic tetrahydroazepinones (and thiones) |
01/18/1989 | EP0299467A1 Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
01/18/1989 | EP0299449A2 Pyridazinone, triazinone and oxapyridazinone lipoxygenase inhibiting compounds |
01/18/1989 | EP0299424A2 Thiosulfinic-acid derivatives, and the use of thiosulfin-acid derivatives for the manufacture of a medicament for the treatment of inflammatory diseases |
01/18/1989 | EP0299376A2 Prostanoid compositions and methods for reducing blood vessel dysfunction |
01/18/1989 | CN1030411A New amino acid derivatives, process for preparation thereof and pharmaceutical composition comprising same |
01/17/1989 | US4798843 Hypotensive agents |
01/17/1989 | US4798841 Tetrahydropyridine oxime cholinergic agents and method of treatment |
01/17/1989 | US4798834 Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement |
01/17/1989 | US4798832 Pyrido[1,2-a]pyrimidine compounds, corresponding intermediates and use as SRS-A antagonists |
01/17/1989 | US4798829 Gastrointestinal disorders, migraine headaches |
01/12/1989 | WO1989000194A1 Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides |
01/12/1989 | WO1989000161A1 Malic acid derivative containing renin inhibiting peptides |
01/11/1989 | EP0298818A1 1-Benzenesulfonyl 2-oxo 5-alkylthio pyrrolidines, process for their preparation, their intermediaries and their use as medicines |
01/11/1989 | EP0298280A2 Animal derived cell with antigenic protein introduced therein |
01/11/1989 | EP0298134A1 Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same |
01/11/1989 | EP0298121A1 Biocompatible material for treatment of defects in tissues and organs |
01/10/1989 | US4797506 Antiulcer agents |
01/10/1989 | US4797405 Stabilized pergolide compositions |
01/10/1989 | US4797397 X-rays therapy of tumors |
01/10/1989 | CA1248526A1 [3.2.0]bicycloheptanone oxime ethers with valuable therapeutic properties |
01/10/1989 | CA1248448A1 PURIFICATION OF BIOLOGICALLY ACTIVE HUMAN IMMUNE INTERFERON-.gamma. |
01/04/1989 | EP0297855A1 Aminocyclopentyl ethers and their preparation and pharmaceutical formulation |
01/04/1989 | EP0297770A1 Novel HMG-COA reductase inhibitors |
01/04/1989 | EP0297681A2 Iron-calcium mineral supplements with enhanced bioavailability |
01/04/1989 | EP0297651A1 Anellated indole derivatives |
01/04/1989 | EP0297621A2 Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions containing them |
01/04/1989 | EP0297610A1 N-[(2,6-disubstituted)phenyl]-urea and carbamate inhibitors of acyl-CoA:cholesterol acyl-transferase |
01/04/1989 | CN1030075A Substituted pyrroles |
01/04/1989 | CN1030074A Leukotriene antagonists |
01/03/1989 | US4795814 Process for preparing novel dihydropyridine derivatives |
01/03/1989 | US4795808 Antitumor |
01/03/1989 | US4795804 Polypeptide |
01/03/1989 | US4795754 Antiallergens |
01/03/1989 | CA1248298A1 Amino-thioalkyl structured radiation protection agents and their preparation |
01/03/1989 | CA1248112A1 1,3,4-thiadiazole derivatives, process for the production thereof and use thereof as antiulcer agent |
01/03/1989 | CA1248098A1 Process for preparing fenoldopam 4',8-bis-hydrogen sulfates |
12/29/1988 | WO1988010269A1 Growth factors |
12/29/1988 | WO1988010266A1 Cysteine proteinase inhibitor |
12/28/1988 | EP0296979A2 1-Benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them |
12/28/1988 | EP0296978A2 1-Benzyl 2-oxo 5-alkoxy pyrrolidine derivatives, process for their preparation, compositions containing them and their use in medicines |
12/28/1988 | EP0296811A2 Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma |
12/28/1988 | EP0296802A1 Aminocyclopentyl ethers and their preparation and pharmaceutical formulation |
12/28/1988 | EP0296748A1 Cycloalkylamides of (8Beta)-1-alkyl-6-(substituted) ergolines |
12/28/1988 | EP0296732A1 Leukotriene antagonists |
12/28/1988 | EP0296731A1 Leukotriene antagonists |
12/28/1988 | EP0296620A2 Use of N-acetylneuraminic-acid salts for the preparation of a medicament for decongesting nasal mucous membranes |
12/28/1988 | EP0296580A2 Phenylene, furyl, and thienyl leukotriene B4 analogues |
12/28/1988 | EP0296374A2 Glycosylated aminoacids and peptides |
12/28/1988 | EP0296236A1 Nasal delivery of caffeine |
12/28/1988 | CN88103784A Novel n-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
12/28/1988 | CN88101606A Treatment of human viral infection by dsrna combined with viral inhibitors |
12/28/1988 | CN88100519A 5-(3-alkyl-5-tert. butyl-4-hydroxyphenyl) -2-amino-6h-1,3,4-thiadiazine |
12/27/1988 | US4794169 Pentapeptides with cell growth regulatory effects and a process for the preparation thereof |
12/27/1988 | US4794114 Inhibition of interleukin-1 production by monocytes and/or macrophages |
12/27/1988 | US4793998 Stabilized drug compositions |
12/21/1988 | EP0295883A1 Process for intermediates to leukotriene antagonists |
12/21/1988 | EP0295882A1 Process for intermediates to leukotriene antagonists |
12/21/1988 | EP0295851A1 4,7-diacyloxybenzofuran derivatives |
12/21/1988 | EP0295827A2 Use of 24,25-dihydroxy-cholecalciferol in mending bone fractures |
12/21/1988 | EP0295742A1 Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
12/21/1988 | EP0295721A2 Promotion of healing of meniscal tissue |
12/21/1988 | EP0295559A2 Pharmaceutical composition for the treatment of tumours |
12/21/1988 | EP0295317A1 Pharmaceutical composition for the treatment of tumors |
12/21/1988 | CN88103091A Phosphorus-containing hmg-c0a reductase inhibitors, new intermediates and method |
12/20/1988 | US4792555 Phospholipase A2 inhibitors |
12/20/1988 | US4792550 Thromboxane antagonist-hypotensive agent; cardiovascular, nervous system disorders; antiallergens |
12/20/1988 | CA1247096A1 Chemical compounds |
12/15/1988 | WO1988009794A1 Cyclopolyglycuronic acid composition and its use |
12/15/1988 | WO1988009659A1 Pharmaceutical or cosmetic preparation containing hydroquinone and kojic acid |
12/15/1988 | WO1988009378A3 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
12/15/1988 | WO1988008836A3 Aryl substituted naphthalene, benzoxepine, benzazepine, benzocycloheptene derivatives |
12/14/1988 | EP0295056A1 Anti-inflammatory furanones |
12/14/1988 | EP0294973A1 Dopamine-beta-hydroxylase inhibitors |
12/14/1988 | EP0294937A2 Novel cinnamoylamide derivatives |
12/14/1988 | EP0294615A1 Cyclobutene-3,4-dione-intermediates and their use in the preparation of histamine h2-antagonists |